PET/CT imaging of renal cell carcinoma with 18F-VM4-037: a phase II pilot study

作者: Baris Turkbey , Maria L. Lindenberg , Stephen Adler , Karen A. Kurdziel , Yolanda L. McKinney

DOI: 10.1007/S00261-015-0599-1

关键词: KidneyImaging biomarkerMalignancyRenal cell carcinomaClear cell renal cell carcinomaMedicineHepatologyCystParenchymaInternal medicinePathology

摘要: … (TAC) were generated from the 45 min dynamic scans for the primary tumor lesion, the aorta, to generate a blood TAC and … The 80% max was used for the aorta TAC to help offset partial …

参考文章(23)
Daniel P Donato, Matthew T Johnson, Ximing J Yang, Debra L Zynger, Expression of carbonic anhydrase IX in genitourinary and adrenal tumours. Histopathology. ,vol. 59, pp. 1229- 1239 ,(2011) , 10.1111/J.1365-2559.2011.04074.X
George Sgouros, Chaitanya R. Divgi, Joseph A. O'Donoghue, Devie Deland, Sydney Welt, Sydney Welt, Andrew M. Scott, Andrew M. Scott, Seza Gulec, Aparna Nakhre, Lloyd J. Old, Lloyd J. Old, Francesca Morrissey, Martin C. Graham, Jeanne M. Williams, Peter Capitelli, Neil H. Bander, Neil H. Bander, Neil H. Bander, Egbert Oosterwijk, Egbert Oosterwijk, Ronald D. Finn, Steven M. Larson, Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clinical Cancer Research. ,vol. 4, pp. 2729- 2739 ,(1998)
Alexander B. Stillebroer, Otto C. Boerman, Ingrid M.E. Desar, Marije J. Boers-Sonderen, Carla M.L. van Herpen, Johannes F. Langenhuijsen, Peter M. Smith-Jones, Egbert Oosterwijk, Wim J.G. Oyen, Peter F.A. Mulders, Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma European Urology. ,vol. 64, pp. 478- 485 ,(2013) , 10.1016/J.EURURO.2012.08.024
W. MARSTON LINEHAN, McCLELLAN M. WALTHER, BERTON ZBAR, The Genetic Basis of Cancer of the Kidney The Journal of Urology. ,vol. 170, pp. 2163- 2172 ,(2003) , 10.1097/01.JU.0000096060.92397.ED
William G Kaelin Jr, None, The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer Nature Reviews Cancer. ,vol. 8, pp. 865- 873 ,(2008) , 10.1038/NRC2502
Brian Shuch, Eric A. Singer, Gennady Bratslavsky, The Surgical Approach to Multifocal Renal Cancers: Hereditary Syndromes, Ipsilateral Multifocality, and Bilateral Tumors Urologic Clinics of North America. ,vol. 39, pp. 133- 148 ,(2012) , 10.1016/J.UCL.2012.01.006
William Makis, Anthony Ciarallo, Rajan Rakheja, Stephan Probst, Marc Hickeson, Christopher Rush, Javier-A. Novales-Diaz, Vilma Derbekyan, Jerry Stern, Robert Lisbona, Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay Clinical Imaging. ,vol. 36, pp. 660- 673 ,(2012) , 10.1016/J.CLINIMAG.2012.01.010
Jean‐Jacques Patard, Patricia Fergelot, Pierre I Karakiewicz, Tobias Klatte, Quoc‐Dien Trinh, Nathalie Rioux‐Leclercq, Jonathan W Said, Arie S Belldegrun, Allan J Pantuck, None, Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma International Journal of Cancer. ,vol. 123, pp. 395- 400 ,(2008) , 10.1002/IJC.23496
E B Rankin, A J Giaccia, The role of hypoxia-inducible factors in tumorigenesis. Cell Death & Differentiation. ,vol. 15, pp. 678- 685 ,(2008) , 10.1038/CDD.2008.21
William Y. Kim, William G. Kaelin, Role of VHL Gene Mutation in Human Cancer Journal of Clinical Oncology. ,vol. 22, pp. 4991- 5004 ,(2004) , 10.1200/JCO.2004.05.061